CHANGES IN NEUTROPENIA OUTCOMES FOLLOWING IMPLEMENTATION OF THE CLOZAPINE RISK EVALUATION AND MITIGATION STRATEGY UPDATE

被引：0
|
作者：
Chang, J. [1 ]
Taylor, K. [1 ]
Wei, Y. [1 ]
Huang, T. Y. [1 ]
机构：
[1] Komodo Hlth, San Francisco, CA USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EPH16
引用
收藏
页码：S156 / S156
页数：1
相关论文
共 50 条
  • [41] The Risk Evaluation and Mitigation Strategy (REMS) Public Dashboard: Improving Transparency of Regulatory Activities
    Toyserkani, Gita A.
    Lee, Joann H.
    Zhou, Esther H.
    PHARMACEUTICAL MEDICINE, 2023, 37 (5) : 349 - 353
  • [42] Communicating drug safety and safe use conditions in risk evaluation and mitigation strategy materials
    Sarpatwari, Ameet
    Tessema, Frazer A.
    Mitra-Majumdar, Mayookha
    Lee, Su Been
    Zakoul, Heidi
    Brown, Beatrice L.
    Toyserkani, Gita A.
    Oswell, Kate
    Shaw, Katherine Hyatt Hawkins
    Zendel, Laura
    LaCivita, Cynthia
    Dal Pan, Gerald J.
    Avorn, Jerry
    Kesselheim, Aaron S.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 299 - 300
  • [43] Mifepristone and misoprostol in California pharmacies after modifications to the Risk Evaluation and Mitigation Strategy Program
    Beshar, Isabel
    Miller, Hayley E.
    Kruger, Samantha
    Henkel, Andrea
    CONTRACEPTION, 2024, 137
  • [44] JCL roundtable: Risk evaluation and mitigation strategy (vol 10, pg 1288, 2016)
    Kynamro, D. Per
    JOURNAL OF CLINICAL LIPIDOLOGY, 2017, 11 (01) : 311 - 311
  • [45] Risk Evaluation and Mitigation Strategy (REMS): FDA Perspective on What Physicians Need to Know
    Slatko, Gary H.
    AMERICAN FAMILY PHYSICIAN, 2015, 92 (09) : 771 - 772
  • [46] Issues and Critiques of the Forthcoming Risk Evaluation and Mitigation Strategy (REMS) for Opioids in Pain Management
    Peppin, John F.
    Coleman, John J.
    Kirsh, Kenneth L.
    ISSUES IN LAW & MEDICINE, 2011, 27 (02) : 91 - 119
  • [47] Assessment of Australian Sea Lion Bycatch Mortality in a Gillnet Fishery, and Implementation and Evaluation of an Effective Mitigation Strategy
    Goldsworthy, Simon D.
    Page, Brad
    Hamer, Derek J.
    Lowther, Andrew D.
    Shaughnessy, Peter D.
    Hindell, Mark A.
    Burch, Paul
    Costa, Daniel P.
    Fowler, Shannon L.
    Peters, Kristian
    McIntosh, Rebecca R.
    Bailleul, Frederic
    Mackay, Alice I.
    Kirkwood, Roger
    Holman, Dirk
    Bryars, Simon
    FRONTIERS IN MARINE SCIENCE, 2022, 9
  • [48] LONGITUDINAL OUTCOMES FOLLOWING IMPLEMENTATION OF BASELINE PSA RISK STRATIFICATION OF MEN IN THEIR FORTIES
    Michael, Zoe
    Kotamarti, Srinath
    Arcot, Rohith
    Morris, Kostantinos
    Shah, Anand
    Anderson, John
    Armstrong, Andrew
    Gupta, Rajan
    Preminger, Glenn M.
    Moul, Judd W.
    Oeffinger, Kevin
    Shah, Kevin
    Polascik, Thomas J.
    JOURNAL OF UROLOGY, 2022, 207 (05): : E143 - E143
  • [49] Longitudinal outcomes following implementation of baseline PSA risk stratification of men in their forties
    Michael, Z. D.
    Kotamarti, S.
    Arcot, R.
    Morris, K.
    Shah, A.
    Anderson, J.
    Armstrong, A.
    Gupta, R.
    Preminger, G. M.
    Moul, J. W.
    Oeffinger, K.
    Shah, K.
    Polascik, T. J.
    EUROPEAN UROLOGY, 2022, 81 : S567 - S568
  • [50] Therapy timetabling, an evaluation of outcomes following implementation at the Oxfordshire Stroke Rehabilitation Unit
    Garratt, E.
    King, S.
    INTERNATIONAL JOURNAL OF STROKE, 2019, 14 (4_SUPPL) : 20 - 20
12345